Insider buying last 90 days
No open-market insider purchases were filed for SBRA in the last 90 days.
From Form 4 filings, dated to when each was filed.
Nov 13 close
Sabra Health Care REIT moves this week on third-quarter results and related developments. The company reported higher normalized funds from operations with continued growth in its senior housing operating portfolio, and management raised full-year normalized FFO guidance midpoint by $0.005 per share, with third-quarter same-store senior housing occupancy reaching 89.2%. Results also included a $100 million write-off tied to a $300 million Recovery Centers of America mortgage loan that was satisfied with a reduced $200 million cash payment. Separately, Huntington Sec initiated coverage with a "strong-buy" rating, and the company declared a quarterly dividend of $0.30 per share, representing a 6.0% annual yield, payable 30 November to holders of record 13 November.
The stock closes at $21.47, up 2.1%, sitting between its 50-day average of $19.88 and 200-day average of $20.02. The GekkoIndex reads 43.4, placing the stock in the Distribution zone, down 12.2 points over the last five readings. Shares trade 33.6% below Gekko Fair Value of $32.34.
The next earnings date falls on 11 February 2027, 93 days out, beyond a typical 20-day holding window. No insider, Congress or unusual options activity appears in their respective windows. Seasonally, the next 20 trading days have averaged -2.4% over 5 years, rising in 2 of them, a pattern worth noting alongside the current Distribution reading.
Written by AI from the Nov 9, 2026 close and checked automatically against the figures on this page.
Sabra Health Care REIT scores 2 supportive, 2 mixed and 1 headwind across the 5 checklist items with data.
Six things swing traders check before a 20-day hold, read from the latest data.
2 supportive2 mixed1 headwind
Averages disagree
Close $20.44 sits between the 50-day ($19.88) and 200-day ($20.06) averages, or the averages disagree.
See the chart54.4, Neutral
Reading 54.4 is in the Neutral zone.
See the GekkoIndex33.1% below
Price is 33.1% below Gekko Fair Value (more than 5% below).
See fair valueNo data
No insider, Congress or unusual options activity in the window.
See smart moneyReports in 88 days
Next report Feb 11, 2027, 88 days away — outside a typical 20-trading-day hold.
See earnings−2.7% on average
From this point in the calendar, the next 20 trading days averaged −2.7% over 5 years, rising in 2 of them.
See seasonalityA description of current data, not a recommendation. How this page works
Sabra Health Care REIT closed at $20.44 on Nov 13, 2026, +8.3% over the past year, inside a 52-week range of $17.54 to $22.77.
Use the left and right arrow keys to read daily values.
Put SBRA on a Gekko watchlist and see its GekkoIndex, Gekko Fair Value and smart money signals update on the chart as they change.
Sabra Health Care REIT is engaged in the acquisition, financing, and ownership of real estate property. Its core activity involves building up holdings of property assets through purchase and funding arrangements, positioning the company within the real estate investment space. This work of acquiring and holding property is the primary way the company is known.
The company generates its earnings by owning and financing the real estate it acquires, with its business structured around the management of these property holdings. Its operations center on the cycle of obtaining properties, arranging the financing needed to support that ownership, and retaining these assets over time.
Sabra Health Care REIT was founded on May 10, 2010, and its headquarters are located in Tustin, California. The company's shares trade under the ticker SBRA.
Sabra Health Care REIT’s GekkoIndex — Gekko’s 0 to 100 smart money score — reads 54.4, in the Neutral zone, up 9.5 points over five sessions.
Up 9.5 points over five sessions, from the Distribution zone.
Reading for Nov 13, 2026
| Zone | Readings | 5 days | 20 days | ||
|---|---|---|---|---|---|
| Buying | 25 | +0.9% | +5.0% | ||
| Accumulation | 161 | +0.6% | +2.7% | ||
| Neutral (current zone) | 434 | +0.2% | +0.7% | ||
| Distribution | 35 | −0.5% | −1.4% | ||
| Selling | 0 | Not available | |||
Average SBRA share-price change over the trading days after each daily reading in its GekkoIndex history. Across every stock Gekko tracks, Neutral readings averaged +0.9% over 20 days. Past behaviour doesn’t guarantee future results.
Neutral zone: No clear directional signal. About the five zones →
Sabra Health Care REIT trades 33.1% below Gekko Fair Value of $30.54, so the shares are undervalued on Gekko’s estimate.
Gekko’s own estimate of what Sabra Health Care REIT shares are worth, recalculated every trading day.
$30.54
Gekko Fair Value, Nov 14, 2026
33.1% Undervalued
At the end of Aug 2026 the price was 44.3% below the estimate.
No open-market insider purchases were filed for Sabra Health Care REIT, and no Congress trades were disclosed, in the last 90 days.
Plus buybacks, unusual options and fund positions, each dated to when it became public.
No open-market insider purchases were filed for SBRA in the last 90 days.
From Form 4 filings, dated to when each was filed.
No trades in SBRA were disclosed by members of Congress in the last 90 days.
From congressional disclosures, which report amounts as ranges.
Sabra Health Care REIT has been buying back its own shares.
From company filings.
Sabra Health Care REIT reports on Feb 11, 2027 (88 days away), and beat the EPS estimate in 3 of its last 8 reports.
Feb 11, 2027
88 days away
| Reported | EPS | Revenue | Move |
|---|---|---|---|
| Feb 12, 2026 | $0.38 est $0.17 | $211.9M est $198.0M | +2.9% |
| Oct 29, 2025 | $0.17 est $0.18 | $190.0M est $202.0M | −1.6% |
| Aug 4, 2025 | $0.38 est $0.37 | $189.2M est $187.5M | −0.6% |
| May 6, 2025 | $0.17 est $0.14 | $183.5M est $182.5M | +4.6% |
| Feb 25, 2025 | $0.17 est $0.17 | — | +3.2% |
| Oct 31, 2024 | $0.13 est $0.16 | $178.0M est $175.6M | −4.8% |
| Aug 7, 2024 | $0.10 est $0.15 | $178.5M est $166.0M | −0.1% |
| May 8, 2024 | $0.11 est $0.14 | $172.2M est $162.0M | −1.7% |
“Move” is the close of the first session after the report compared with the close of the last session before it, so it reads the same whether the company reported before the open or after the close.
Analysts’ average 12-month price target for Sabra Health Care REIT is $22.64, +10.8% from the last close, from 6 firms rating the stock in the last 90 days.
Each firm’s latest rating in the last 90 days: 6 firms.
| Date | Firm | Target | vs price |
|---|---|---|---|
| Nov 11 | UBS | $22 | +7.6% |
| Nov 9 | Bank of America Securities | $25 | +22.3% |
| Nov 3 | Wells Fargo | $21 | +2.7% |
| Nov 3 | Scotiabank | $20 | −2.2% |
| Oct 19 | Wells Fargo | $21 | +2.7% |
Gekko doesn’t publish price predictions. These are analyst targets and historical base rates, which don’t guarantee future results.
Over the next 20 trading days from Nov 14, Sabra Health Care REIT averaged −2.7% across the last 5 years, rising in 2 of them.
| Window | Average | Years higher |
|---|---|---|
| Next 5 trading days | −1.3% | 1 of 5 |
| Next 10 trading days | −1.1% | 3 of 5 |
| Next 15 trading days | −1.3% | 2 of 5 |
| Next 20 trading days | −2.7% | 2 of 5 |
| Next 30 trading days | −3.3% | 2 of 5 |
For scale, SBRA’s typical 20-trading-day move in either direction is about 4.3%.
Sabra Health Care REIT’s market cap is $5.35B, with a P/E ratio of 76.2 and revenue of $924.3M over the last twelve months.
3 headlines about Sabra Health Care REIT from the past week, newest first, each linking to the publisher.
Sabra Health Care REIT’s market cap is $5.35B at the Nov 13, 2026 close of $20.44, with 262.0M shares outstanding. The shares trade on a P/E ratio of 76.2.
The consensus analyst 12-month price target for Sabra Health Care REIT is $22.64, +10.8% from the last close. Of the 6 firms that rated the stock in the last 90 days, 2 rate it a buy, 4 a hold and 0 a sell. Gekko doesn’t publish price predictions of its own.
On Gekko’s estimate Sabra Health Care REIT is undervalued: the Nov 13, 2026 close of $20.44 is 33.1% below Gekko Fair Value of $30.54. Gekko Fair Value is recalculated every trading day, and a gap inside 5% either way counts as about fair value.
Sabra Health Care REIT is expected to report on Feb 11, 2027 (88 days away). Analysts expect earnings of $0.16 per share on revenue of $246.9M. Sabra Health Care REIT beat the earnings estimate in 3 of its last 8 reports, moving 2.4% on average across the report.
Sabra Health Care REIT’s 52-week high is $22.77 and its 52-week low is $17.54; it closed at $20.44 on Nov 13, 2026, +8.3% over the past year.
Gekko describes the data; it does not make buy or sell recommendations. On the swing-trade checklist, 2 of the 5 items with data read as supportive (fair value and earnings risk), 2 as mixed (trend and gekkoindex) and 1 as a headwind (seasonality). The checklist is a description of current data, not a recommendation.
During US trading hours the price at the top of the page is a delayed quote, refreshed every 15 minutes; everything else is rebuilt after each US market close. The GekkoIndex, Gekko Fair Value and the checklist are Gekko’s own, and the Gekko Brief is written by AI from this page’s data and checked against it before it is published. How Gekko’s data works →
Every GekkoIndex reading, insider trade, options bet and Congress disclosure plotted on the chart, plus the 5,800-name screener and trade planning tools.
Join 1,475 other traders using Gekko
Start Your FREE 7 Day Trial → Every feature unlocked. No credit card required.Type a ticker or company name. Press Esc to close.